In General, SMOs have a major issue to cover wide range of disease experiences by crossing the boarder, and to maintain and train the specialty as SMO. CSIA–SMO, however, share the cultivated specialty within the 4 companies including lots of support experiences of global CROs and small venture to worldwide big pharm. executed studies to fulfill the customer satisfaction, also with additional information regarding the actual Asian clinical condition and environment.

Over 1000 studies leads to set up the training system which is specialized in the objective disease of our customer for providing the best performance with reliability. As a rooted SMO in each regions, CSIA–SMO will provide precious information to the customer by strong and good relationship with investigational institutions

In General, mid sized CROs have a major issue to cover wide range of disease experiences by crossing the boarder, and to maintain and train the specialty as a CRO. CSIA–CRO, however, share the cultivated specialty within the 3 companies including IND submission to US–FDA to fulfill the customer satisfaction, also with additional information regarding the actual Asian clinical condition and environment from CSIA–SMO.

Over 1000 studies including the experiences from CSIA–SMO leads to set up the training system which is specialized in the objective disease of our customer for providing the best performance with reliability. As a rooted CRO in each regions, CSIA–CRO will provide precious information to the customer by strong and good relationship with investigational institutions with cooperation of CSIA–SMO.

^∗CSIA–CRO has been experiencing major disease such as oncology and CNS that are trends in clinical development all over the world, and cultivated all the related skills to satisfy customer needs.

It is very important for the customer that CSIA–CRO has a variety experiences to support various issues from the beginning to the end for achievement of the customer satisfaction.